QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

XOMA

QT68XOMA Royalty Corp.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
41.89
+0.17+0.41%
OverviewShort InterestFilings
XOMAQT68XOMA Royalty Corp.·NASDAQ
OverviewShort InterestFilings
41.89+0.41%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E15.75EPS (ttm)
1.57
Insider Own43.94%
Shs Outstand17.68M
Perf Week0.22%
Market Cap523.21MForward P/E-EPS next Y-0.05Insider Trans0.44%Shs Float-Perf Month0.84%
Enterprise Value553.48MPEG-EPS next Q0.18Inst Own-Short Float-Perf Quarter45.65%
Income33.22MP/S14.44EPS this Y-49.99%Inst Trans-Short Ratio-Perf Half Y62.18%
Sales36.23MP/B4.40EPS next Y-106.10%ROA11.59%Short Interest-Perf YTD57.54%
Book/sh6.39P/C74.80EPS next 5Y12.33%ROE30.21%52W High42.81 -2.15%Perf Year75.05%
Cash/sh5.37P/FCF78.87EPS past 3/5Y-ROIC1.94%52W Low22.29 87.93%Perf 3Y-
Dividend Est.-EV/EBITDA11.04Sales past 3/5Y105.41% 12.39%Gross Margin93.29%Volatility0.63% 0.59%Perf 5Y-
Dividend TTM-EV/Sales15.28EPS Y/Y TTM125.45%Oper. Margin13.73%ATR (14)0.47Perf 10Y-
Dividend Ex-Date-Quick Ratio3.59Sales Y/Y TTM25.00%Profit Margin86.97%RSI (14)59.23Recom2.33
Dividend Gr. 3/5Y-Current Ratio3.59EPS Q/Q183.33%SMA200.16%Beta1.04Target Price44.50
Payout17.54%Debt/Eq1.10Sales Q/Q-25.00%SMA502.18%Rel Volume0.38Prev Close41.72
Employees13LT Debt/Eq1.13EarningsAug 12SMA20026.04%Avg Volume232.38KPrice41.89
IPO DateJun 06, 1986Option/ShortYes / YesEPS/Sales Surpr.-10.53% 0.00%Net Debt/EBITDA0.60Volume88,326Change0.41%
Analyst Ratings
DateActionAnalystRatingTarget
Apr-30-26ReiteratedH.C. Wainwright$97 → $39
Apr-30-26DowngradeHC Wainwright & Co.Buy → Neutral
Feb-24-26ReiteratedLeerink PartnersOutperform$45 → $50
Dec-12-25ReiteratedStifel Nicolaus$50
Dec-11-25ReiteratedH.C. Wainwright$104 → $97
Dec-11-25ReiteratedLeerink PartnersOutperform$45
Dec-09-25InitiatedLucid CapitalBuy$76
Sep-07-21DowngradeWedbushOutperform → Neutral
Sep-05-17UpgradeWedbushNeutral → Outperform
Nov-14-16DowngradeWedbushOutperform → Neutral
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue355228
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A330
Gross Profit324928
Selling, General and Administrative Excl. Other403634
Research and Development023
Other Operating Expense-11031
Operating Income611-40
Interest Expense121314
Unusual Expense
———
Non-Operating Income (Expense)-42-33-34
Net Income Before Taxes3332-19
Income Taxes00-6
Consolidated Net Income3132-14
Net Income From Continuing Operations3332-14
Net Income3132-14
EPS (Recurring)1.651.53-1.65
EPS (Basic, Before Extraordinaries)1.651.53-1.65
EPS (Diluted)1.571.46-1.65
EBITDA5048-5
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio26.6818.21—
Price To Sales Ratio14.369.20—
Gross Margin91.4394.23100.00
Operating Margin17.1421.15-142.86
Net Margin88.5761.54-50.00
Shares Outstanding121812
Market Capitalization503479—
Operating Lease Expense
———
Insider Trading Volume
$43.98$39.95$35.92$31.89$27.86● Close Price0.00M0.63M1.25M1.88M2.50MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Trigilio JeffreyChief Financial OfficerApr 20 '26Option Exercise0.0023,0760126,924Apr 22 12:00 AM
Montano Maricel PereaChief Legal OfficerApr 20 '26Option Exercise0.006,740041,793Apr 22 12:00 AM
Hughes OwenChief Executive OfficerApr 20 '26Option Exercise0.0021,1360191,264Apr 22 12:00 AM
Sitko BradleyChief Investment OfficerApr 20 '26Option Exercise0.007,474082,961Apr 22 12:00 AM
Trigilio JeffreyChief Financial OfficerApr 13 '26Option Exercise0.008,000094,000Apr 15 12:00 AM
LIMBER JOSEPH MDirectorMar 27 '26Option Exercise11.206,05267,7829,234Mar 31 12:00 AM
WYSZOMIERSKI JACK LDirectorMar 24 '26Option Exercise11.206,05267,78221,530Mar 26 12:00 AM
Hughes OwenChief Executive OfficerDec 04 '25Buy25.05100,0002,505,000102,000Dec 08 12:00 AM
BURNS THOMAS M.SVP, Finance & CFOSep 22 '25Sale35.994,330155,82030,079Sep 23 12:00 AM
BURNS THOMAS M.SVP, Finance & CFOSep 19 '25Option Exercise0.0023,692044,208Sep 23 12:00 AM
Montano Maricel PereaChief Legal OfficerSep 19 '25Option Exercise0.006,066012,134Sep 23 12:00 AM
Sitko BradleyChief Investment OfficerSep 19 '25Option Exercise0.0013,424023,488Sep 23 12:00 AM
Hughes OwenChief Executive OfficerSep 19 '25Option Exercise0.0071,1340132,714Sep 23 12:00 AM
Montano Maricel PereaChief Legal OfficerSep 10 '25Option Exercise0.0018,202014,349Sep 12 12:00 AM
Sitko BradleyChief Investment OfficerJun 30 '25Buy25.392,00050,7807,045Jul 02 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR